Preferred Pharmaceuticals, Inc recalls Ranitidine Tablets, USP 150 mg, OTC, a.) 30 count bottle (NDC 68788-7078-03), b.) 60 count bottle (NDC 68788-7078-06),
Preferred Pharmaceuticals recalls 150mg Ranitidine Tablets due to detected NDMA impurity. Consumers should stop using these products immediately.
Stop using this now
CGMP Deviations: Presence of NDMA impurity detected in product.
Contact the company & request your remedy
What happened, in plain English
Preferred Pharmaceuticals is recalling 150mg Ranitidine Tablets in 30-count and 60-count bottles because they contain NDMA impurity. This impurity could pose health risks, so affected consumers should stop using the product. Read more at govinfonow.com/recall/37665-preferred-pharmaceuticals-ranitidine-tablets-150mg-recall-ndma-impurity-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/37665-preferred-pharmaceuticals-ranitidine-tablets-150mg-recall-ndma-impurity-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0617-2020
Cite this page
“Preferred Pharmaceuticals Ranitidine Tablets 150mg Recall: NDMA Impurity Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37665-preferred-pharmaceuticals-ranitidine-tablets-150mg-recall-ndma-impurity-risk. Based on FDA recall #D-0617-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0617-2020%22&limit=1).
Why it’s dangerous
The product contains NDMA impurity, which has been linked to health risks. This impurity was detected during manufacturing and may cause health problems if consumed.
Who’s affected
People who own or use the recalled 150mg Ranitidine Tablets (30-count or 60-count bottles) are affected. Those with the product are at risk of potential health issues.
How to tell if you have this one
Check for 150mg Ranitidine Tablets in 30-count or 60-count bottles with NDC numbers 68788-7078-03 or 68788-7078-06. The product was manufactured by Amneal Pharmaceuticals.
- Brand
Preferred Pharmaceuticals- Category
Drug
What to do — step by step
Stop Using Product
Immediately stop using the recalled Ranitidine Tablets and dispose of them safely.
Questions people ask
Why is this product being recalled?
The product contains NDMA impurity, which has been detected during manufacturing and may pose health risks.
What is the NDC number for the recalled product?
The NDC numbers are 68788-7078-03 (30-count) and 68788-7078-06 (60-count).
How can I check if I have the recalled product?
Check for 150mg Ranitidine Tablets in 30-count or 60-count bottles with NDC numbers 68788-7078-03 or 68788-7078-06.
Contact Preferred Pharmaceuticals
We’ve drafted a message you can send Preferred Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-0617-2020 — Preferred Pharmaceuticals Preferred Pharmaceuticals Hello, I own a Preferred Pharmaceuticals that is covered by recall D-0617-2020 from Preferred Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0617-2020 (December 2, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0617-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.